Cardiac Harms of Sofosbuvir: Systematic Review and Meta-Analysis
ConclusionsThe pooled data from RCTs did not show an increased risk of cardiac outcomes, including arrhythmias (and bradycardia), among sofosbuvir-treated patients, although the overall quality of the evidence supporting this conclusion was very low.Registration: PROSPERO 2016:CRD42016033109 athttp://www.crd.york.ac.uk/PROSPERO/.
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research
More News: Amiodarone | Arrhythmia | Clinical Trials | Databases & Libraries | Drugs & Pharmacology | Hepatitis | Hepatitis C | Study